Alignment HealthcarevsThermo Fisher Scientific

ALHC and TMO stock compared: price, dividend, valuation and results, from SEC filings.

ALHC

Alignment Healthcare, Inc.

$7.62

Value $1.6B

+2.01%
ALHC's page

TMO

Thermo Fisher Scientific Inc

$686.79

Value $255B

-0.66%
TMO's page

Alignment Healthcare (ALHC) has a market value of $1.6B and Thermo Fisher Scientific (TMO) $255B. Over the last year, with dividends, ALHC moved -53.9% and TMO +19.1%. The P/E is 53.8 for ALHC and 36.1 for TMO. Dividend yield: ALHC none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ALHC$1.6B

    TMO$255B

    TMO is 164 times ALHC

  • Revenue, 12 months

    ALHC$4.9B

    TMO$47.4B

    TMO is 9.6 times ALHC

  • Net income, 12 months

    ALHC$29M

    TMO$7.1B

    TMO is 245 times ALHC

  • Operating margin

    ALHC0.9%

    TMO17.9%

    17.0 points apart

  • ROIC

    ALHC6.4%

    TMO8.2%

    1.8 points apart

  • P/E

    ALHC53.8

    TMO36.1

    ALHC is 1.5 times TMO

  • Dividend yield

    ALHC0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    ALHC-66.7%

    TMO+8.6%

    75.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ALHC-66.7%

TMO+8.6%

5010020222023202420252026
Returns by period
PeriodALHCWith dividendsTMOWith dividends
1 year since November 14, 2025-53.9%Price -53.9%+19.1%Price +18.7%
3 years since November 17, 2023+16.5%+5.2% a yearPrice +16.5%+48.7%+14.1% a yearPrice +47.2%
5 years since November 16, 2021-66.7%-19.7% a yearPrice -66.7%+8.6%+1.7% a yearPrice +7.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ALHCAlignment HealthcareTMOThermo Fisher Scientific

Valuation

ALHCTMO
Valuation
Price$7.62$686.79
Market value$1.6B$255B
Enterprise value (EV)$1.1B$290B
P/E53.836.1
P/E, 5-year median–32.7
P/B5.64.7
EV/EBIT26.234.3
Free cash flow yield5.0%3.0%

Results and growth

ALHCTMO
Results and growth
Revenue, 12 months$4.9B$47.4B
Net income, 12 months$29M$7.1B
Free cash flow, 12 months$77M$7.6B
Earnings per share, 12 months$0.13$18.96
Revenue growth, year on year46.1%3.9%
Revenue growth a year, past+32.7%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

ALHCTMO
Margins and returns on capital
Gross margin––
Operating margin0.9%17.9%
Net margin0.6%14.9%
ROIC6.4%8.2%
ROE13.3%13.4%

Balance sheet

ALHCTMO
Balance sheet
Cash$743M$6.1B
Total debt$324M$41.4B
Net debt / EBITDA-5.73.7
Interest cover2.6×5.5×

Dividends and buybacks

ALHCTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ALHC or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Alignment Healthcare or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($255B) is about 163.9 times Alignment Healthcare ($1.6B), at today's prices.

How did ALHC and TMO stock do over the last 5 years?

Since November 16, 2021, ALHC's price moved -66.7% and TMO's +7.1%. With dividends: ALHC -66.7% (-19.7% a year), TMO +8.6% (+1.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, ALHC or TMO?

The dividend yield at today's price is none for Alignment Healthcare and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of ALHC and TMO?

At today's price, the P/E is 53.8 for ALHC and 36.1 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Alignment Healthcare or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 0.6% for Alignment Healthcare and 14.9% for Thermo Fisher Scientific, and the operating margin 0.9% and 17.9%. Revenue was $4.9B and $47.4B.

Which is the better investment, Alignment Healthcare or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.